Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose. [electronic resource]
Producer: 20090326Description: 769-71 p. digitalISSN:- 1476-5365
- Adult
- Aged
- Antilymphocyte Serum -- immunology
- Antineoplastic Agents -- therapeutic use
- Female
- HLA Antigens -- immunology
- Hematopoietic Stem Cells -- immunology
- Humans
- Leukemia -- therapy
- Male
- Middle Aged
- Recurrence
- Siblings
- Stem Cell Transplantation
- Transplantation Conditioning -- methods
- Vidarabine -- analogs & derivatives
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.